Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% from the June 30th total of 19,200 shares. Based on an average daily volume of 844,800 shares, the short-interest ratio is currently 0.0 days.
Q BioMed Stock Up 50.0 %
Shares of Q BioMed stock traded up $0.06 on Thursday, hitting $0.18. The stock had a trading volume of 1,781,116 shares, compared to its average volume of 233,217. Q BioMed has a one year low of $0.04 and a one year high of $0.90. The stock has a market cap of $7.43 million, a price-to-earnings ratio of -0.58 and a beta of 1.74. The stock's 50-day simple moving average is $0.08 and its two-hundred day simple moving average is $0.23.
Get Q BioMed alerts:Q BioMed Company Profile
(Get Rating)
Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.See Also
- Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
- Is Keurig-Dr. Pepper A Value Worth Buying?
- C3.AI Stock is a Bargain Enterprise Artificial Intelligence Game Changer
- Did The FOMC Put A Bottom In The S&P 500?
- Two High Yield ETF That Can Substitute For Index Funds
- A Closer Look At Disney: Can It Earn a Place in Your Portfolio?
Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.